Status:
ACTIVE_NOT_RECRUITING
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Acute Leukemia
Acute Lymphoblastic Leukemia
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. Most children with leukemia and lymphoblastic...
Detailed Description
PRIMARY OBJECTIVE: I. Determine the effectiveness of high intensity program (HIP)-eHealth on pediatric cancer survivors' learning and school-related outcomes up to 12 months post-enrollment. SECONDA...
Eligibility Criteria
Inclusion
- Documented informed consent of the participant and/or legally authorized representative
- Assent, when appropriate, will be obtained per institutional guidelines
- Primary participating parent/caregiver is English- or Spanish-speaking (any race/ethnicity)
- Child is aged 6-12 years (yr.) (for the website usability pre-study, child is age 8 - 12 yrs.)
- Child understands English (but can be bilingual)
- Child treated for acute leukemia (e.g., acute lymphoblastic leukemia, acute myelogenous leukemia) or lymphoblastic lymphoma
- Child is in cancer remission and has completed cancer therapies, including maintenance treatment
- Primary participating parent/caregiver has daily contact with the child
- Child is enrolled in school
Exclusion
- Recent or current participation in a behavioral intervention study with a similar focus
- History of major psychiatric condition (e.g., psychosis) in parent or child
- Severe neurodevelopmental disorder in the child (e.g., down syndrome, intellectual disability)
- Child has previously used the IXL online learning program extensively and unwilling to regularly use it again
- Any other condition that would, in the investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns with clinical study procedures
- Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)
Key Trial Info
Start Date :
February 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2027
Estimated Enrollment :
342 Patients enrolled
Trial Details
Trial ID
NCT05428176
Start Date
February 16 2023
End Date
June 30 2027
Last Update
December 3 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010
2
Childrens Hospital of Los Angeles
Los Angeles, California, United States, 90027
3
Rady Children's Hospital San Diego
San Diego, California, United States, 92123
4
University of Calif San Francisco
San Francisco, California, United States, 94115